Literature DB >> 21764651

Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Brian L Teng1, Kathryn E Hacker, Shufen Chen, Anthony R Means, W Kimryn Rathmell.   

Abstract

Pin1 specifically recognizes and catalyzes the cis-trans isomerization of phosphorylated-Ser/Thr-Pro bonds, which modulate the stability, localization, and function of numerous Pin1 targets involved in tumor progression. However, the role of Pin1 in cancer remains enigmatic as the gene is located on chromosome 19p13.2, which is a region subject to loss of heterozygosity in several tumors. Since Pin1 protein is frequently under-expressed in kidney cancer, we have explored its role in human clear cell renal cell carcinoma (ccRCC). Here we show evidence for PIN1 gene deletion and mRNA under-expression as a mechanism of Pin1 reduction in ccRCC tumors. We demonstrate that restoration of Pin1 in cell lines found to be deficient in Pin1 protein expression can attenuate the growth of ccRCC cells in soft agar and a xenograft tumor model. Moreover, this ability of Pin1 to negatively influence tumor growth in ccRCC cells may be dependent on the presence of functional p53, which is infrequently mutated in ccRCC. These observations suggest Pin1 may have a mild tumor suppressive role in ccRCC.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764651      PMCID: PMC3194764          DOI: 10.1016/j.molonc.2011.06.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  34 in total

1.  A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.

Authors:  Elizabeth Yeh; Melissa Cunningham; Hugh Arnold; Dawn Chasse; Teresa Monteith; Giovanni Ivaldi; William C Hahn; P Todd Stukenberg; Shirish Shenolikar; Takafumi Uchida; Christopher M Counter; Joseph R Nevins; Anthony R Means; Rosalie Sears
Journal:  Nat Cell Biol       Date:  2004-03-14       Impact factor: 28.824

2.  Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

Authors:  A Rose Brannon; Anupama Reddy; Michael Seiler; Alexandra Arreola; Dominic T Moore; Raj S Pruthi; Eric M Wallen; Matthew E Nielsen; Huiqing Liu; Katherine L Nathanson; Börje Ljungberg; Hongjuan Zhao; James D Brooks; Shridar Ganesan; Gyan Bhanot; W Kimryn Rathmell
Journal:  Genes Cancer       Date:  2010-02-01

3.  Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Authors:  Brian L Teng; Kathryn E Hacker; Shufen Chen; Anthony R Means; W Kimryn Rathmell
Journal:  Mol Oncol       Date:  2011-06-28       Impact factor: 6.603

4.  IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry.

Authors:  Han You; Hongwu Zheng; Steven A Murray; Qiang Yu; Takafumi Uchida; Daiming Fan; Zhi-Xiong Jim Xiao
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

5.  Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC.

Authors:  A Ryo; M Nakamura; G Wulf; Y C Liou; K P Lu
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

6.  Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).

Authors:  Ping Yi; Ray-Chang Wu; Joshua Sandquist; Jiemin Wong; Sophia Y Tsai; Ming-Jer Tsai; Anthony R Means; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  No germline TP53 mutations detected in familial and bilateral testicular cancer.

Authors:  K Heimdal; R A Lothe; S Lystad; R Holm; S D Fosså; A L Børresen
Journal:  Genes Chromosomes Cancer       Date:  1993-02       Impact factor: 5.006

8.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Netrin-1 controls colorectal tumorigenesis by regulating apoptosis.

Authors:  Laetitia Mazelin; Agnès Bernet; Christelle Bonod-Bidaud; Laurent Pays; Ségolène Arnaud; Christian Gespach; Dale E Bredesen; Jean-Yves Scoazec; Patrick Mehlen
Journal:  Nature       Date:  2004-09-02       Impact factor: 49.962

10.  p53 pathway in renal cell carcinoma is repressed by a dominant mechanism.

Authors:  Katerina V Gurova; Jason E Hill; Olga V Razorenova; Peter M Chumakov; Andrei V Gudkov
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

View more
  10 in total

Review 1.  Landscape of Pin1 in the cell cycle.

Authors:  Cheng-Han Lin; Hao-Yi Li; Yu-Cheng Lee; Marcus J Calkins; Kuen-Haur Lee; Chia-Ning Yang; Pei-Jung Lu
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-07

Review 2.  Pin1 dysregulation helps to explain the inverse association between cancer and Alzheimer's disease.

Authors:  Jane A Driver; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2015-01-10

3.  Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma.

Authors:  Brian L Teng; Kathryn E Hacker; Shufen Chen; Anthony R Means; W Kimryn Rathmell
Journal:  Mol Oncol       Date:  2011-06-28       Impact factor: 6.603

4.  Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Finger Proteins in Clear Cell Renal Carcinoma.

Authors:  Simone O Heyliger; Karam F A Soliman; Marilyn D Saulsbury; R Renee Reams
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

5.  Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.

Authors:  Neal R Rasmussen; Tricia M Wright; Samira A Brooks; Kathryn E Hacker; Zufan Debebe; Adam B Sendor; Matthew P Walker; Michael Ben Major; Jennifer Green; Geoffrey M Wahl; W Kimryn Rathmell
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

Review 6.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

7.  Expression of peptidyl-prolyl isomerase PIN1 and its role in the pathogenesis of extrahepatic cholangiocarcinoma.

Authors:  Urangoo Jamiyandorj; Jun Sang Bae; Sang Jae Noh; Sarangerel Jachin; Ji Eun Choi; Kyu Yun Jang; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Woo Sung Moon
Journal:  Oncol Lett       Date:  2013-08-12       Impact factor: 2.967

8.  Dynamic regulation of Pin1 expression and function during zebrafish development.

Authors:  Maria Solange Ibarra; Carla Borini Etichetti; Carolina Di Benedetto; Germán L Rosano; Ezequiel Margarit; Giannino Del Sal; Marina Mione; Javier Girardini
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

9.  Pin1 modulates p63α protein stability in regulation of cell survival, proliferation and tumor formation.

Authors:  C Li; D L Chang; Z Yang; J Qi; R Liu; H He; D Li; Z X Xiao
Journal:  Cell Death Dis       Date:  2013-12-05       Impact factor: 8.469

Review 10.  Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1.

Authors:  Dongmei Chen; Long Wang; Tae Ho Lee
Journal:  Front Cell Dev Biol       Date:  2020-03-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.